The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients

The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients

Objectives:. The recent conflicting data on the mortality benefit of neuromuscular blocking agents in acute respiratory distress syndrome and the potential adverse effects of continuous neuromuscular blocking agent necessitates that these medications should be used judiciously with dose reduction in...

Full description

Bibliographic Details
Main Authors: Sarah Hadique, MD, Varun Badami, MD, Michael Forte, MD, Nicole Kovacic, PharmD, BCCCP, Amna Umer, PhD, Amanda Shigle, PharmD, Jordan Gardo, BSN, RN, CCRN, Rahul Sangani, MD
Format: Article
Language:English
Published: Wolters Kluwer 2021-03-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000371

Internet

http://journals.lww.com/10.1097/CCE.0000000000000371

Similar Items